Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bertin

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Cell Death & Disease|November 11, 2016
RIPK1 protects from TNF-α-mediated liver damage during hepatitisAveline Filliol, Claire Piquet-Pellorce, Jacques Le Seyec, et al.
Journal of Pharmaceutical Sciences|June 23, 2020
Understanding Pharmacokinetic Disconnect in Preclinical Species for 4-Aminoquinolines: Consequences of Low Permeability and High P-glycoprotein Efflux Ratio on Rat and Dog Oral PharmacokineticsMukesh K Mahajan, Elizabeth J Rivera, Helen H Sun, et al.
Cells|April 30, 2021
Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1Yulin Ouyang, Li Wen, Jane A Armstrong, et al.
Cell Death & Disease|February 3, 2017
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic functionKay Hänggi, Lazaros Vasilikos, Aida Freire Valls, et al.
The Journal of Biological Chemistry|September 10, 2005
Nod1 participates in the innate immune response to Pseudomonas aeruginosaLeonardo H Travassos, Leticia A M Carneiro, Stephen E Girardin, et al.
Cell Reports|March 25, 2015
Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1Malek Najjar, Chalada Suebsuwong, Soumya S Ray, et al.
Nature|January 13, 2006
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3Thirumala-Devi Kanneganti, Nesrin Ozören, Mathilde Body-Malapel, et al.
Immunity|July 12, 2016
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4Malek Najjar, Danish Saleh, Matija Zelic, et al.
FEBS Letters|January 11, 2005
Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD proteinHa-Na Woo, Gil-Sun Hong, Joon-Il Jun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Cell Death & Disease|November 11, 2016
RIPK1 protects from TNF-α-mediated liver damage during hepatitisAveline Filliol, Claire Piquet-Pellorce, Jacques Le Seyec, et al.
Journal of Pharmaceutical Sciences|June 23, 2020
Understanding Pharmacokinetic Disconnect in Preclinical Species for 4-Aminoquinolines: Consequences of Low Permeability and High P-glycoprotein Efflux Ratio on Rat and Dog Oral PharmacokineticsMukesh K Mahajan, Elizabeth J Rivera, Helen H Sun, et al.
Cells|April 30, 2021
Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1Yulin Ouyang, Li Wen, Jane A Armstrong, et al.
Cell Death & Disease|February 3, 2017
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic functionKay Hänggi, Lazaros Vasilikos, Aida Freire Valls, et al.
The Journal of Biological Chemistry|September 10, 2005
Nod1 participates in the innate immune response to Pseudomonas aeruginosaLeonardo H Travassos, Leticia A M Carneiro, Stephen E Girardin, et al.
Cell Reports|March 25, 2015
Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1Malek Najjar, Chalada Suebsuwong, Soumya S Ray, et al.
Nature|January 13, 2006
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3Thirumala-Devi Kanneganti, Nesrin Ozören, Mathilde Body-Malapel, et al.
Immunity|July 12, 2016
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4Malek Najjar, Danish Saleh, Matija Zelic, et al.
FEBS Letters|January 11, 2005
Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD proteinHa-Na Woo, Gil-Sun Hong, Joon-Il Jun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Pageof 12